PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) Deficiency

PSY27 A Cost-Effectiveness Comparison of Icatibant and C1-Esterase Inhibitor Concentrate for the Symptomatic Treatment of Acute Attacks of Types I and II Hereditary Angioedema in the UK Setting

Value in Health ◽

10.1016/j.jval.2012.08.1750 ◽

2012 ◽

Vol 15 (7) ◽

pp. A513 ◽

Cited By ~ 1

Author(s):

M. Helbert ◽

F. Pang ◽

M. Alvarez-Reyes ◽

I. Pearson ◽

S. Wolowacz ◽

...

Keyword(s):

Cost Effectiveness ◽

Hereditary Angioedema ◽

Symptomatic Treatment ◽

C1 Esterase Inhibitor ◽

Acute Attacks ◽

The Uk ◽

Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial

Annals of Allergy Asthma & Immunology ◽

10.1016/j.anai.2011.10.017 ◽

2012 ◽

Vol 108 (1) ◽

pp. 49-53 ◽

Cited By ~ 22

Author(s):

Marc A. Riedl ◽

David S. Hurewitz ◽

Robyn Levy ◽

Paula J. Busse ◽

David Fitts ◽

...

Keyword(s):

Hereditary Angioedema ◽

Open Label ◽

C1 Esterase Inhibitor ◽

Open Label Trial ◽

Acute Attacks ◽

C1-Esterase Inhibitor Concentrate For Acute Attacks Of Laryngeal Edema In Hereditary Angioedema (HAE): Fixed Dosing Vs Body Weight-Adjusted Dosing

10.1016/j.jaci.2013.12.155 ◽

2014 ◽

Vol 133 (2) ◽

pp. AB37

Author(s):

Konrad Bork ◽

Jonathan A. Bernstein ◽

Henrike Feuersenger ◽

Thomas Machnig ◽

Timothy J. Craig

Keyword(s):

Body Weight ◽

Hereditary Angioedema ◽

Laryngeal Edema ◽

C1 Esterase Inhibitor ◽

Acute Attacks ◽

Association of C1 Esterase-Inhibitor Functional Activity and Treatment Response With C1 Esterase-Inhibitor Concentrate (Berinert®) for Acute Attacks of Hereditary Angioedema

10.1016/j.jaci.2011.12.115 ◽

2012 ◽

Vol 129 (2) ◽

pp. AB223

Author(s):

A.K. Bewtra ◽

D.S. Hurewitz ◽

J.A. Bernstein ◽

T. Machnig ◽

H. Keinecke ◽

...

Keyword(s):

Treatment Response ◽

Hereditary Angioedema ◽

Functional Activity ◽

C1 Esterase Inhibitor ◽

Acute Attacks ◽

C1 esterase inhibitor (C1-INH) - Standard of Care for the Treatment of Acute Attacks in Hereditary Angioedema (HAE): Initial Results of an Ongoing, Prospective, Open Label Study in North America (I.M.P.A.C.T.2)

10.1016/j.jaci.2007.12.392 ◽

2008 ◽

Vol 121 (2) ◽

pp. S98-S99 ◽

Cited By ~ 4

Author(s):

T CRAIG ◽

R WASSERMANN ◽

R LEVY ◽

A BEWTRA ◽

D HUREWITZ ◽

...

Keyword(s):

North America ◽

Hereditary Angioedema ◽

Standard Of Care ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

C1 Esterase Inhibitor ◽

Acute Attacks ◽

Initial Results ◽

Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema

Pediatric Allergy and Immunology ◽

10.1111/pai.12444 ◽

2015 ◽

Vol 26 (7) ◽

pp. 674-680 ◽

Cited By ~ 17

Author(s):

William Lumry ◽

Daniel Soteres ◽

Richard Gower ◽

Kraig W. Jacobson ◽

H. Henry Li ◽

...

Keyword(s):

Hereditary Angioedema ◽

Safety And Efficacy ◽

C1 Esterase Inhibitor ◽

Acute Attacks ◽

C1 Esterase Inhibitor (C1-INH) Concentrate in the Treatment of Acute Attacks in Hereditary Angioedema: Interim Results of the Treatment of 975 Attacks in an Ongoing, Prospective, Open-Label Study in North America (I.M.P.A.C.T.2)

10.1016/j.jaci.2009.12.650 ◽

2010 ◽

Vol 125 (2) ◽

pp. AB166 ◽

Cited By ~ 1

Author(s):

S. Goodman ◽

R. Levy ◽

R. Wasserman ◽

A. Bewtra ◽

D. Hurewitz ◽

...

Keyword(s):

North America ◽

Hereditary Angioedema ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

C1 Esterase Inhibitor ◽

Acute Attacks ◽

C1 Esterase Inhibitor Concentrate (C1-INH) for the Treatment of Acute Attacks of Hereditary Angioedema: Interim Results of an Ongoing, Prospective, Open Label Study in North America after 640 attacks (I.M.P.A.C.T.2)

10.1016/j.jaci.2008.12.358 ◽

2009 ◽

Vol 123 (2) ◽

pp. S99-S99 ◽

Cited By ~ 2

Author(s):

R.L. Levy ◽

R.L. Wasserman ◽

A.K. Bewtra ◽

D.H. Hurewitz ◽

J.N. Moy ◽

...

Keyword(s):

North America ◽

Hereditary Angioedema ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

C1 Esterase Inhibitor ◽

Acute Attacks ◽

Faculty Opinions recommendation of Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725641802.793534460 ◽

2017 ◽

Author(s):

Timothy Craig

Keyword(s):

Hereditary Angioedema ◽

Safety And Efficacy ◽

C1 Esterase Inhibitor ◽

Acute Attacks ◽

Allergy & Clinical Immunology International - Journal of the World Allergy Organization ◽

Anaphylaxis in Response to C1 Esterase Inhibitor in a Patient with Hereditary Angioedema

10.1027/0838-1925.19.4.159 ◽

2007 ◽

Vol 19 (4) ◽

pp. 159-163 ◽

Cited By ~ 3

Author(s):

Marco Cicardi ◽

Lorenza Zingale ◽

Andrea Zanichelli ◽

Daniela Lambertenghi Deliliers

Keyword(s):

Hereditary Angioedema ◽

C1 Esterase Inhibitor ◽